Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCG | P05129 | 8/20 | 0.55 |
| ▸ | PRKCB | P05771 | 8/20 | 0.55 |
| ▸ | PRKCA | P17252 | 8/20 | 0.55 |
| ▸ | PRKCE | Q02156 | 8/20 | 0.55 |
| ▸ | PRKCH | P24723 | 7/20 | 0.55 |
| ▸ | PRKCD | Q05655 | 7/20 | 0.55 |
| ▸ | CAMK2D | Q13557 | 7/20 | 0.55 |
| ▸ | CAMK2B | Q13554 | 6/20 | 0.55 |
| ▸ | CAMK2G | Q13555 | 6/20 | 0.55 |
| ▸ | CAMK2A | Q9UQM7 | 6/20 | 0.55 |
| ▸ | PRKCZ | Q05513 | 5/20 | 0.55 |
| ▸ | PIP5K1C | O60331 | 1/20 | 0.55 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.55 |
| ▸ | RPS6KA4 | O75676 | 1/20 | 0.55 |
| ▸ | STK16 | O75716 | 1/20 | 0.55 |
| ▸ | PAK3 | O75914 | 1/20 | 0.55 |
| ▸ | CDK14 | O94921 | 1/20 | 0.55 |
| ▸ | MET | P08581 | 1/20 | 0.55 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.55 |
| ▸ | KIT | P10721 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7524369 | 0.78 | PRKCG (0.69) | PRKCGPRKCBPRKCAPRKCEPRKCH | |
| Hydrochloric Acid SCHEMBL29784988 | 0.72 | PRKCG (0.77) | PRKCGPRKCBPRKCAPRKCEPRKCH | |
| Enzastaurin SCHEMBL29371538 | 0.71 | PRKCG (1.00) | PRKCGPRKCBPRKCAPRKCEPRKCH | |
| Enzastaurin SCHEMBL678748 | 0.71 | PRKCG (1.00) | PRKCGPRKCBPRKCAPRKCEPRKCH | |
| Enzastaurin SCHEMBL29356867 | 0.71 | PRKCG (1.00) | PRKCGPRKCBPRKCAPRKCEPRKCH | |
| Enzastaurin SCHEMBL16934851 | 0.71 | PRKCG (1.00) | PRKCGPRKCBPRKCAPRKCEPRKCH | |
| Enzastaurin SCHEMBL4877354 | 0.71 | PRKCG (1.00) | PRKCGPRKCBPRKCAPRKCEPRKCH | |
| Enzastaurin SCHEMBL4325665 | 0.71 | PRKCG (0.98) | PRKCGPRKCBPRKCAPRKCEPRKCH | |
| Enzastaurin SCHEMBL29371570 | 0.71 | PRKCG (1.00) | PRKCGPRKCBPRKCAPRKCEPRKCH | |
| SCHEMBL14555078 | 0.70 | PRKCG (0.62) | PRKCGPRKCBPRKCAPRKCEPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250367097-A1 | COMPOSITIONS AND FORMULATIONS FOR USE OF A PK INHIBITOR FOR THE PREVENTION, TREATMENT, AND IMPROVEMENT OF SKIN DISEASES, CONDITIONS, AND DISORDERS | DERMBIONT INC (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250228822-A1 | COMPOSITIONS AND FORMULATIONS FOR USE OF A PK INHIBITOR FOR THE PREVENTION, TREATMENT, AND IMPROVEMENT OF SKIN DISEASES, CONDITIONS, AND DISORDERS | DERMBIONT, INC. | 2025-07-17 | — | — | US | disclosed |
| US-12290506-B2 | Compositions and formulations for use of a PK inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disorders | DERMBIONT, INC. (US) | 2025-05-06 | — | — | US | disclosed |
| US-20240293368-A1 | COMPOSITIONS AND FORMULATIONS FOR USE OF A PK INHIBITOR FOR THE PREVENTION, TREATMENT, AND IMPROVEMENT OF SKIN DISEASES, CONDITIONS, AND DISORDERS | DERMBIONT, INC. | 2024-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250367097-A1 | COMPOSITIONS AND FORMULATIONS FOR USE OF A PK INHIBITOR FOR THE PREVENTION, TREATMENT, AND IMPROVEMENT OF SKIN DISEASES, CONDITIONS, AND DISORDERS | SERPINB1, CUTA, PNPO | PRKCG 863/4885PRKCB 486/4885PRKCA 564/4885 |
| US-20250228822-A1 | COMPOSITIONS AND FORMULATIONS FOR USE OF A PK INHIBITOR FOR THE PREVENTION, TREATMENT, AND IMPROVEMENT OF SKIN DISEASES, CONDITIONS, AND DISORDERS | SERPINB1, CUTA, PNPO | PRKCG 863/4885PRKCB 486/4885PRKCA 564/4885 |
| US-12290506-B2 | Compositions and formulations for use of a PK inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disorders | SERPINB1, CUTA, PNPO | PRKCG 863/4885PRKCB 486/4885PRKCA 564/4885 |
| US-20240293368-A1 | COMPOSITIONS AND FORMULATIONS FOR USE OF A PK INHIBITOR FOR THE PREVENTION, TREATMENT, AND IMPROVEMENT OF SKIN DISEASES, CONDITIONS, AND DISORDERS | SERPINB1, CUTA, PNPO | PRKCG 863/4885PRKCB 486/4885PRKCA 564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.